USA 116 , 26722680 (2019)
Of note, the effects of these natural products on APAP hepatotoxicity were tested only by pretreatment method
For example, the FDA recognized that off-label uses of Transmucosal Immediate Release Fentanyl (TIRF) drugs in non-cancer pain had exceeded on-label uses, but went on to approve Subsys in 2012 because having another option that is different in formulation, in this case a sublingual spray, is helpful to patients. In contrast, payors often denied coverage for the use of TIRF medicines beyond break-through cancer pain due to the high cost of these medicines
The consensus in the scientific community supports B12s high safety profile, even at elevated levels, with no documented risk of toxicity in healthy individuals
the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed